1. Home
  2. NVCT vs CAAS Comparison

NVCT vs CAAS Comparison

Compare NVCT & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • CAAS
  • Stock Information
  • Founded
  • NVCT 2020
  • CAAS N/A
  • Country
  • NVCT United States
  • CAAS China
  • Employees
  • NVCT N/A
  • CAAS N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • CAAS Auto Parts:O.E.M.
  • Sector
  • NVCT Health Care
  • CAAS Consumer Discretionary
  • Exchange
  • NVCT Nasdaq
  • CAAS Nasdaq
  • Market Cap
  • NVCT 170.3M
  • CAAS 137.0M
  • IPO Year
  • NVCT 2022
  • CAAS N/A
  • Fundamental
  • Price
  • NVCT $9.77
  • CAAS $4.42
  • Analyst Decision
  • NVCT Strong Buy
  • CAAS
  • Analyst Count
  • NVCT 2
  • CAAS 0
  • Target Price
  • NVCT $15.00
  • CAAS N/A
  • AVG Volume (30 Days)
  • NVCT 128.5K
  • CAAS 54.8K
  • Earning Date
  • NVCT 05-06-2025
  • CAAS 03-28-2025
  • Dividend Yield
  • NVCT N/A
  • CAAS N/A
  • EPS Growth
  • NVCT N/A
  • CAAS N/A
  • EPS
  • NVCT N/A
  • CAAS 0.99
  • Revenue
  • NVCT N/A
  • CAAS $650,935,000.00
  • Revenue This Year
  • NVCT N/A
  • CAAS $4.97
  • Revenue Next Year
  • NVCT N/A
  • CAAS N/A
  • P/E Ratio
  • NVCT N/A
  • CAAS $4.82
  • Revenue Growth
  • NVCT N/A
  • CAAS 12.94
  • 52 Week Low
  • NVCT $4.44
  • CAAS $3.34
  • 52 Week High
  • NVCT $11.80
  • CAAS $5.37
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 60.31
  • CAAS 46.82
  • Support Level
  • NVCT $8.45
  • CAAS $4.17
  • Resistance Level
  • NVCT $10.67
  • CAAS $5.37
  • Average True Range (ATR)
  • NVCT 0.99
  • CAAS 0.26
  • MACD
  • NVCT 0.08
  • CAAS 0.01
  • Stochastic Oscillator
  • NVCT 72.98
  • CAAS 17.39

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: